NCT05622578Completed
Phenotyping of Chronic Pain in Diffused Systemic Scleroderma
Phenotyping of Chronic Pain in Diffused Systemic Scleroderma: Characteristics and Perturbations of Mechanisms of Pain, Impact on the Quality of Life and Correlations of Fatigue, Sleeping Disorders and Mood or Anxiety Disorders
Source: ClinicalTrials.gov · Last updated 4 Dec 2024
Brief summary (registry, in English)
The primary objective of the study is to describe the different phenotyping of pain in systemic scleroderma patients and perturbations of mechanisms of the pain. As secondary objectives, the study aims to describe the importances of overall symptoms in alteration of quality of life and conserve the questions which will be associated in a unique questionnaire in order to evaluate the pain, the fatigue and the sleeping disorders in diffused systemic scleroderma patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 26 Sept 2022
- Start date
- 19 Oct 2022
- Primary completion date
- 19 Dec 2023
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Systemic sclerosis (scleroderma)
- NCT number
- NCT05622578
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 19 Oct 2022 to the primary completion date, 19 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Articular pain from degenerative diseases (known osteoarthritis);
Other
- Patients unable to understand french language;
- Patients no-affiliated to the french social security scheme;
- Patients under the french AME scheme;
- Patients under guardianship;
- Pregnant and breastfeeding patients;
- Patients with thermoalgesic neuropathy;
- Patients under antidepressant;
- Temporary discontinuation of analgesics which are not well tolerated.
Who the study is looking for
- Patients ≥ 18 years;
- Patients with diffused SSc according to ACR / EULAR Classification 2013 since at least 3 months;
- For group pain: pain intensity ≥4 of 11 points of scale (NRS);
- For group painless: pain intensity on the month before inclusion.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center of evaluation and treatment of pain - Cochin hospital - APHP Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.